Furthermore, our study explored the effects of the polymorphic genotypes of FGFR4 on the clinicopathological status of OSCC, which includes TNM clinical staging, tumor size, lymph node involvement, and cell differentiation (Table 4). The gene discussed is FGFR4; the disease is neoplasm.